Recovery from chronic spinal cord contusion after nogo receptor intervention

Annals of Neurology

Volumn 70, Issue 5, 2011, Pages 805-821

  Wang, Xingxing ^a   Duffy, Philip ^a   McGee, Aaron W ^a,b   Hasan, Omar ^a   Gould, Grahame ^a   Tu, Nathan ^a   Harel, Noam Y ^a   Huang, Yiyun ^a   Carson, Richard E ^a   Weinzimmer, David ^a   Ropchan, Jim ^a   Benowitz, Larry I ^c   Cafferty, William B J ^a   Strittmatter, Stephen M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN; PROTEIN NGR1; PROTEIN NOGO; PROTEIN RTN4R; RECOMBINANT PROTEIN; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CONTUSION; DRUG MECHANISM; FEMALE; GENE DELETION; GENE TARGETING; IMMUNOHISTOLOGY; IN VIVO STUDY; KINEMATICS; LOCOMOTION; MOTOR PERFORMANCE; MOUSE; NERVE FIBER GROWTH; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; SPINAL CORD CONTUSION; SPINAL CORD INJURY; VIDEORECORDING; WEIGHT BEARING;

ANIMALS; AXONS; DISEASE MODELS, ANIMAL; INJECTIONS, SPINAL; LOCOMOTION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; MYELIN PROTEINS; NEUROPSYCHOLOGICAL TESTS; RECOMBINANT FUSION PROTEINS; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 83255193053     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22527     Document Type: Article

References (72)

1. Rossignol S, Schwab M, Schwartz M, Fehlings MG,. Spinal cord injury: time to move? J Neurosci 2007; 27: 11782-11792.
2. Liu BP, Cafferty WB, Budel SO, Strittmatter SM,. Extracellular regulators of axonal growth in the adult central nervous system. Philos Trans R Soc Lond B Biol Sci 2006; 361: 1593-1610.
3. Maier IC, Schwab ME,. Sprouting, regeneration and circuit formation in the injured spinal cord: factors and activity. Philos Trans R Soc Lond B Biol Sci 2006; 361: 1611-1634.
4. Bradbury EJ, McMahon SB,. Spinal cord repair strategies: why do they work? Nat Rev Neurosci 2006; 7: 644-653.
5. Courtine G, Song B, Roy RR, et al. Recovery of supraspinal control of stepping via indirect propriospinal relay connections after spinal cord injury. Nat Med 2008; 14: 69-74.
6. Rosenzweig ES, Courtine G, Jindrich DL, et al. Extensive spontaneous plasticity of corticospinal projections after primate spinal cord injury. Nat Neurosci 2010; 13: 1505-1510.
7. Cafferty WB, Duffy P, Huebner E, Strittmatter SM,. MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J Neurosci 2010; 30: 6825-6837.
8. Cafferty WB, McGee AW, Strittmatter SM,. Axonal growth therapeutics: regeneration or sprouting or plasticity? Trends Neurosci 2008; 31: 215-220.
9. Spinal cord injury, facts and figures at a glance. Birmingham, AL: National Spinal Cord Injury Statistical Center, 2006.
10. Kadoya K, Tsukada S, Lu P, et al. Combined intrinsic and extrinsic neuronal mechanisms facilitate bridging axonal regeneration one year after spinal cord injury. Neuron 2009; 64: 165-172.
11. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, et al. Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. J Neurosci 2010; 30: 1657-1676.
12. Tom VJ, Sandrow-Feinberg HR, Miller K, et al. Combining peripheral nerve grafts and chondroitinase promotes functional axonal regeneration in the chronically injured spinal cord. J Neurosci 2009; 29: 14881-14890.
13. Fournier AE, GrandPre T, Strittmatter SM,. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 2001; 409: 341-346.
14. Dimou L, Schnell L, Montani L, et al. Nogo-A-deficient mice reveal strain-dependent differences in axonal regeneration. J Neurosci 2006; 26: 5591-5603.
15. Cafferty WB, Strittmatter SM,. The Nogo-Nogo receptor pathway limits a spectrum of adult CNS axonal growth. J Neurosci 2006; 26: 12242-12250.
16. Cafferty WB, Kim JE, Lee JK, Strittmatter SM,. Response to correspondence: Kim et al., "Axon regeneration in young adult mice lacking Nogo-A/B." Neuron 38, 187-199. Neuron 2007; 54: 195-199.
17. Lee JK, Geoffroy CG, Chan AF, et al. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice. Neuron 2010; 66: 663-670.
18. Kim JE, Li S, GrandPre T, et al. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron 2003; 38: 187-199.
19. Simonen M, Pedersen V, Weinmann O, et al. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 2003; 38: 201-211.
20. Kim JE, Liu BP, Park JH, Strittmatter SM,. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron 2004; 44: 439-451.
21. Lee JK, Kim JE, Sivula M, Strittmatter SM,. Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J Neurosci 2004; 24: 6209-6217.
22. Zheng B, Atwal J, Ho C, et al. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc Natl Acad Sci U S A 2005; 102: 1205-1210.
23. Atwal JK, Pinkston-Gosse J, Syken J, et al. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 2008; 322: 967-970.
24. Omoto S, Ueno M, Mochio S, et al. Genetic deletion of paired immunoglobulin-like receptor B does not promote axonal plasticity or functional recovery after traumatic brain injury. J Neurosci 2010; 30: 13045-13052.
25. Nakamura Y, Fujita Y, Ueno M, et al. Paired immunoglobulin-like receptor B knockout does not enhance axonal regeneration or locomotor recovery after spinal cord injury. J Biol Chem 2011; 286: 1876-1883.
26. Liebscher T, Schnell L, Schnell D, et al. Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol 2005; 58: 706-719.
27. Wiessner C, Bareyre FM, Allegrini PR, et al. Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats. J Cereb Blood Flow Metab 2003; 23: 154-165.
28. Freund P, Schmidlin E, Wannier T, et al. Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates. Nat Med 2006; 12: 790-792.
29. Zorner B, Schwab ME,. Anti-Nogo on the go: from animal models to a clinical trial. Ann N Y Acad Sci 2010; 1198 (suppl 1): E22-E34.
30. GrandPre T, Li S, Strittmatter SM,. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 2002; 417: 547-551.
31. Li S, Strittmatter SM,. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J Neurosci 2003; 23: 4219-4227.
32. Cao Y, Shumsky JS, Sabol MA, et al. Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat. Neurorehabil Neural Repair 2008; 22: 262-278.
33. Fang PC, Barbay S, Plautz EJ, et al. Combination of NEP 1-40 treatment and motor training enhances behavioral recovery after a focal cortical infarct in rats. Stroke 2010; 41: 544-549.
34. Zai L, Ferrari C, Dice C, et al. Inosine augments the effects of a Nogo receptor blocker and of environmental enrichment to restore skilled forelimb use after stroke. J Neurosci 2011; 31: 5977-5988.
35. Steward O, Sharp K, Yee KM, Hofstadter M,. A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice. Exp Neurol 2008; 209: 446-468.
36. Fournier AE, Gould GC, Liu BP, Strittmatter SM,. Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin. J Neurosci 2002; 22: 8876-8883.
37. Wang X, Baughman KW, Basso DM, Strittmatter SM,. Delayed Nogo receptor therapy improves recovery from spinal cord contusion. Ann Neurol 2006; 60: 540-549.
38. Li S, Liu BP, Budel S, et al. Blockade of nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci 2004; 24: 10511-10520.
39. Harvey PA, Lee DH, Qian F, et al. Blockade of Nogo receptor ligands promotes functional regeneration of sensory axons after dorsal root crush. J Neurosci 2009; 29: 6285-6295.
40. Duffy P, Schmandke A, Sigworth J, et al. Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord. J Neurosci 2009; 29: 15266-15276.
41. Fournier AE, Takizawa BT, Strittmatter SM,. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci 2003; 23: 1416-1423.
42. Dergham P, Ellezam B, Essagian C, et al. Rho signaling pathway targeted to promote spinal cord repair. J Neurosci 2002; 22: 6570-6577.
43. Lehmann M, Fournier A, Selles-Navarro I, et al. Inactivation of Rho signaling pathway promotes CNS axon regeneration. J Neurosci 1999; 19: 7537-7547.
44. Jin Z, Strittmatter SM,. Rac1 mediates collapsin-1-induced growth cone collapse. J Neurosci 1997; 17: 6256-6263.
45. Hayashi S, McMahon AP,. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol 2002; 244: 305-318.
46. Fischer D, He Z, Benowitz LI,. Counteracting the Nogo receptor enhances optic nerve regeneration if retinal ganglion cells are in an active growth state. J Neurosci 2004; 24: 1646-1651.
47. Basso DM, Beattie MS, Bresnahan JC, et al. MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter Animal Spinal Cord Injury Study. J Neurotrauma 1996; 13: 343-359.
48. Young W,. Spinal cord contusion models. Prog Brain Res 2002; 137: 231-255.
49. Park JH, Gimbel DA, GrandPre T, et al. Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition. J Neurosci 2006; 26: 1386-1395.
50. Weinreb PH, Wen D, Qian F, et al. Resolution of disulfide heterogeneity in Nogo receptor I fusion proteins by molecular engineering. Biotechnol Appl Biochem 2010; 57: 31-45.
51. Basso DM, Fisher LC, Anderson AJ, et al. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 2006; 23: 635-659.
52. Basso DM, Beattie MS, Bresnahan JC,. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12: 1-21.
53. Cafferty WB, Yang SH, Duffy PJ, et al. Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans. J Neurosci 2007; 27: 2176-2185.
54. Li S, Kim JE, Budel S, et al. Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury. Mol Cell Neurosci 2005; 29: 26-39.
55. Williams WA, Neumeister A, Nabulsi N, et al. First in human evaluation of [11C]AFM, a novel PET tracer for the serotonin transporter. Neuroimage 2008; 41: T42.
56. Huang Y, Hwang DR, Bae SA, et al. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl) phenylthio]-5-fluoromethylphenylamine ([11C] AFM). Nucl Med Biol 2004; 31: 543-556.
57. Villegas-Perez MP, Vidal-Sanz M, Rasminsky M, et al. Rapid and protracted phases of retinal ganglion cell loss follow axotomy in the optic nerve of adult rats. J Neurobiol 1993; 24: 23-36.
58. Berkelaar M, Clarke DB, Wang YC, et al. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci 1994; 14: 4368-4374.
59. Collazos-Castro JE, Lopez-Dolado E, Nieto-Sampedro M,. Locomotor deficits and adaptive mechanisms after thoracic spinal cord contusion in the adult rat. J Neurotrauma 2006; 23: 1-17.
60. GrandPre T, Nakamura F, Vartanian T, Strittmatter SM,. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 2000; 403: 439-444.
61. Liu K, Lu Y, Lee JK, et al. PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat Neurosci 2010; 13: 1075-1081.
62. Fry EJ, Chagnon MJ, Lopez-Vales R, et al. Corticospinal tract regeneration after spinal cord injury in receptor protein tyrosine phosphatase sigma deficient mice. Glia 2010; 58: 423-433.
63. Shen Y, Tenney AP, Busch SA, et al. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 2009; 326: 592-596.
64. Bareyre FM, Kerschensteiner M, Raineteau O, et al. The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat Neurosci 2004; 7: 269-277.
65. Wang X, Budel S, Baughman K, et al. Ibuprofen enhances recovery from spinal cord injury by limiting tissue loss and stimulating axonal growth. J Neurotrauma 2009; 26: 81-95.
66. McGee AW, Yang Y, Fischer QS, et al. Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor. Science 2005; 309: 2222-2226.
67. Wang X, Baughman KW, Basso DM, Strittmatter SM,. Delayed Nogo receptor therapy improves recovery from spinal cord contusion. Ann Neurol 2006; 60: 540-549.
68. Nessler JA, De Leon RD, Sharp K, et al. Robotic gait analysis of bipedal treadmill stepping by spinal contused rats: characterization of intrinsic recovery and comparison with BBB. J Neurotrauma 2006; 23: 882-896.
69. Pereira JE, Cabrita AM, Filipe VM, et al. A comparison analysis of hindlimb kinematics during overground and treadmill locomotion in rats. Behav Brain Res 2006; 172: 212-218.
70. Steeves JD, Lammertse D, Curt A, et al. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord 2007; 45: 206-221.
71. Harel NY, Strittmatter SM,. Functional MRI and other non-invasive imaging technologies: providing visual biomarkers for spinal cord structure and function after injury. Exp Neurol 2008; 211: 324-328.
72. Fawcett JW, Curt A, Steeves JD, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 2007; 45: 190-205.